<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE OF REVIEW: Bariatric surgery is an important option for the treatment of severe (type III) <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Its role in the management of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in overweight and <z:mp ids='MP_0001261'>obese</z:mp> patients needs to be defined </plain></SENT>
<SENT sid="2" pm="."><plain>RECENT FINDINGS: Intensified medical therapy can achieve target metabolic goals in many but not <z:hpo ids='HP_0000001'>all</z:hpo> patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Bariatric surgery can normalize or improve glycemia in severely <z:mp ids='MP_0001261'>obese</z:mp> patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>The complications of bariatric surgery are significant and include operative mortality, early and late surgical complications and late <z:e sem="disease" ids="C0267975" disease_type="Disease or Syndrome" abbrv="">nutritional deficiencies</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Comparative studies of bariatric surgery versus intensive medical therapy in the management and clinical outcomes of patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> are needed to evaluate relative risk/benefit of each </plain></SENT>
<SENT sid="6" pm="."><plain>Bariatric surgery studies in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> are lacking long-term follow-up metabolic and clinical outcomes data </plain></SENT>
<SENT sid="7" pm="."><plain>SUMMARY: Current data are insufficient to recommend bariatric surgery as a primary treatment for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>However, it can be recommended for patients whose target metabolic control cannot be achieved by intensive glycemic control because of intolerance or inadequate responses to nutritional and pharmacologic treatments </plain></SENT>
</text></document>